Tibor Hlavaty - Department of Gastroenterology, University Hospital Gasthuisberg

基本信息

浏览量：41

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 107 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Switching from Intravenous to Subcutaneous CTP-13 Treatment in IBD Patients – a One-Year Retrospective Study from Large Slovak IBD Centre

Anna Gojdičová,Igor Šturdík,Jozef Tóth, Marek Gojdič, Zuzana Vrablicová,Iveta Čierna, Dagmar Szekyová, Alena Krónerová,Tibor Hlavatý

Gastroenterologie a hepatologieno. 1 (2024): 31-36

引用0浏览0引用

Predictive Value of Infliximab Trough Levels in Maintenance Therapy for 5-Year Sustained Clinical Remission in Patients with Inflammatory Bowel Disease

Yashar Jalali,Anna Gojdicova,Igor Sturdik,Jozef Toth,Tomas Koller,Martin Huorka,Monika Jalali,Juraj Payer,Tibor Hlavaty

Bratislavské lekárske listy/Bratislava medical journal（2023）

引用0浏览0WOS引用

S1059 the Efficacy of Induction Treatment with Guselkumab in Patients with Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History

Brian Bressler,Laurent Peyrin-Biroulet,Jessica R. Allegretti,Kuan-Hsiang G. Huang,Matthew Germinaro,Nicole Shipitofsky,Ye Miao,Hongyan Zhang,Martin Bortlik,Tibor Hlavaty,Toshimitsu Fujii,Brian G. Feagan,Bruce E. Sands,Axel Dignass

AMERICAN JOURNAL OF GASTROENTEROLOGYno. 10 (2023): S806-S807

引用0浏览0引用

Real-world Observational Cohort Study of Treatment Patterns and Safety Outcomes of Infliximab Biosimilar CT-P13 for the Treatment of Inflammatory Bowel Disease (CONNECT-IBD)

Bernd Bokemeyer,Tibor Hlavaty,Matthieu Allez,Pamela Selema,Shahrzad Moosavi,Mary Jane Cadatal,Heather Fowler,Markus Mueller,Katherine F. Liau,Javier P. Gisbert

EXPERT OPINION ON BIOLOGICAL THERAPYno. 8 (2023): 791-800

引用0浏览0WOS引用

Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women with Crohn´s Disease, a Case-Control Study

Tomas Koller,Jana Kollerova,Tibor Hlavaty,Barbora Kadleckova,Juraj Payer

PubMed（2021）

引用4浏览0WOS引用

Seasonal Changes of Circulating 25-Hydroxyvitamin D Correlate with the Lower Gut Microbiome Composition in Inflammatory Bowel Disease Patients

Katarina Soltys,Martina Stuchlikova,Tibor Hlavaty,Barbora Gaalova,Jaroslav Budis,Juraj Gazdarica,Anna Krajcovicova,Zuzana Zelinkova,Tomas Szemes,Daniel Kuba,Hana Drahovska,Jan Turna,Stanislav Stuchlik

Scientific Reports（2020）

引用24浏览0WOSNATURE引用

Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups including patients using ace inhibitors

Hlavaty T,Krajcovicova A

Bratislava Medical Journal-bratislavske Lekarske Listy（2020）

引用0浏览0引用

Guidelines of the Slovak Working Group on IBD in SGS for the Treatment of IBD at Reproductive Age

Zuzana Zelinková, Jozef Baláž,Ivan Bunganič,Iveta Čierna,Laura Gombošová,Miloš Greguš,Tibor Hlavatý,Milan Hlista,Martin Huorka,Barbora Kadlečková,Tomáš Koller,Peter Lietava, Branislav Valach,Jozef Záň,Mária Zakuciová

Gastroenterologie a hepatologie（2020）

引用0浏览0引用

RETRACTION: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab (Retraction of Vol 13, Pg S 410, 2019)

B. Bokemeyer,T. Hlavaty,M. Allez, P. Selema, S. Moosavi,M. J. Cadatal,H. Fowler, R. Cheung,M. Lukas,J. P. Gisbert

JOURNAL OF CROHNS & COLITIS（2020）

引用0浏览0引用

Nuclear and Mitochondrial Circulating Cell-Free DNA is Increased in Patients with Inflammatory Bowel Disease in Clinical Remission

Zuzana Vrablicova, Kristina Tomova,Lubomira Tothova,Janka Babickova,Barbora Gromova,Barbora Konecna,Robert Liptak,Tibor Hlavaty,Roman Gardlik

Frontiers in Medicine（2020）

引用15浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn